tm
Seeing Is Believing
tm
Seeing Is Believing
TARS is currently covered by 7 analysts with an average price target of $66.78. This is a potential upside of $20.35 (43.83%) from yesterday's end of day stock price of $46.43.
Tarsus Pharmaceuticals 's activity chart (see below) currently has 14 price targets and 38 ratings on display. The stock rating distribution of TARS is 89.29% BUY and 10.71% HOLD.
Analysts average stock forecasts to be materialized ratio is 55.42% with an average time for these price targets to be met of 425.5 days.
Highest price target for TARS is $78, Lowest price target is $41, average price target is $61.14.
Most recent stock forecast was given by OREN LIVNAT from HC WAINWRIGHT on 26-Feb-2025. First documented stock forecast 10-Nov-2020.
Currently out of the existing stock ratings of TARS, 25 are a BUY (89.29%), 3 are a HOLD (10.71%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$73
$26.57 (57.23%)
$61
1 months 17 days ago
(26-Feb-2025)
7/10 (70%)
$30.44 (71.52%)
623
Buy
$78
$31.57 (67.99%)
1 months 17 days ago
(26-Feb-2025)
3/4 (75%)
$35.44 (83.27%)
457
Buy
$60
$13.57 (29.23%)
$62
1 months 17 days ago
(26-Feb-2025)
2/5 (40%)
$17.44 (40.98%)
547
Buy
$72
$25.57 (55.07%)
$65
2 months 21 days ago
(22-Jan-2025)
2/8 (25%)
$23.89 (49.66%)
630
Hold
$41
$-5.43 (-11.70%)
$30
4 months 28 days ago
(15-Nov-2024)
2/3 (66.67%)
$-3.83 (-8.54%)
19
What is TARS (Tarsus Pharmaceuticals ) average time for price targets to be met?
Which analyst has the current highest performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?
Which analyst has the current lower performing score on TARS (Tarsus Pharmaceuticals ) with a proven track record?
Which analyst has the most public recommendations on TARS (Tarsus Pharmaceuticals )?
Which analyst is the currently most bullish on TARS (Tarsus Pharmaceuticals )?
Which analyst is the currently most reserved on TARS (Tarsus Pharmaceuticals )?
